95 %Of 19 participants with repeat HIV RNA after ART start, 18/19 (95%) achieved viral suppression (<1,000 c/ml).
KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 12 observations
Gold tier: mechanically validated evidence, with its primary source.
6,677 evidence items · page 152 / 268
95 %Of 19 participants with repeat HIV RNA after ART start, 18/19 (95%) achieved viral suppression (<1,000 c/ml).
KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 12 observations
60 %Estimates of the probability of dying from severe malaria were high in all settings, with medians ranging from 60% to 73%.
Kenyapaludismepublished 2011PloS oneeurope_pmcdocument of 5 observations
28 %Clinics that did not report cervical cancer screening had 28% (9/32) with at least one provider trained to perform cervical cancer screening.
Kenyacancer du col de l'utérusobserved 2017-2018published 2022BMC health services researcheurope_pmcdocument of 10 observationsDOI 10.1186/s12913-022-08984-2
12.5 %Among cancer out-patients in Nairobi, Kenya, 12.5% were at medium risk of malnutrition.
Kenyacancer (non précisé)published 2017Journal of nutritional scienceeurope_pmcdocument of 10 observations
3.7 %Overall, 211 (3.7%) children admitted with malaria died.
Kenyapaludismepublished 2020Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 15 observationsDOI 10.1093/cid/ciz844
5 %Mother-to-child transmission (MTCT) of HIV can be reduced to less than 5% with antiretroviral therapy.
KenyaVIH/sidapublished 2025AIDS research and therapyPubMeddocument of 6 observations
7 %7% of respondents examined clinically had abnormal blood pressure.
Kenyahypertension artériellepublished 2017African Journal of Health SciencesOpenAlexdocument of 33 observations
38 %Prevalence of any tuberculosis (TB) symptom was 38% in Kenya among people living with HIV not on antiretroviral therapy presenting at outpatient clinics.
Kenyatuberculosepublished 2020BMJ openPubMeddocument of 12 observations
2 %Malaria prevalence was 2% in the semi-arid seasonal zone in 2020.
Kenyapaludismeobserved 2020published 2026Malaria journalPubMeddocument of 4 observations
Prostate cancer is the leading cancer in men in sub-Saharan Africa regarding incidence and mortality.
Kenyacancer de la prostatepublished 2021Cancer epidemiology, biomarkers & prevention : a publication of the American Association feurope_pmcdocument of 3 observations
3.2 per_100000PCV10-type IPD incidence in children younger than 5 years was 3.2 cases per 100 000 in the postvaccine era.
KenyaPCV10-type IPDobserved 2012-2016published 2019Lancet (London, England)europe_pmcdocument of 9 observationsDOI 10.1016/s0140-6736(18)33005-8
8.9 %The prevalence of metabolic syndrome was 8.9% overall among Kenyan adults aged ≥30 years seeking care at Kisumu County Hospital.
Kenyasyndrome métaboliquepublished 2020MedicinePubMeddocument of 10 observations
56.3 %56.3% of caregivers sought routine tuberculosis screening in Gem Sub County, Siaya County, Kenya.
Kenyatuberculosepublished 2026PloS onePubMeddocument of 9 observations
96,022 examinationsA total of 96,022 malaria slide examinations were undertaken over the study period in Gezira State, Sudan.
Kenyapaludismeobserved 1999-2009published 2010Malaria journaleurope_pmcdocument of 3 observationsDOI 10.1186/1475-2875-9-172
5.93 odds_ratioThe odds of HIV were six-fold higher among widowed than married women (adjusted odds ratio: 5.93).
KenyaVIH/sidaobserved 2011-2022published 2025BMC public healthPubMeddocument of 12 observations
6,400 life-yearsImplementing paclitaxel instead of bleomycin-vincristine would save approximately 6400 life-years for advanced AIDS-associated Kaposi sarcoma in Kenya.
Kenyaadvanced AIDS-associated Kaposi sarcomapublished 2022The Lancet. Global healthPubMeddocument of 5 observations
49 %The largest share of guideline-adherent cancer-directed therapy was observed in Nairobi (49%).
Kenyacancer du col de l'utéruspublished 2021The oncologisteurope_pmcdocument of 14 observationsDOI 10.1002/onco.13718
47 %Among 422 eligible patients with newly diagnosed HIV-related Kaposi sarcoma in Uganda and Kenya, intervening death was the reason for not performing rapid case ascertainment in 47% of cases.
KenyaHIV-related Kaposi sarcomapublished 2021Cancer epidemiologyPubMeddocument of 7 observations
13,000 deathsIn Kenya, 13000 HIV-positive patients died due to tuberculosis in 2019.
Kenyatuberculose · VIH/sidaobserved 2019published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 10 observations
78 introductionsSeventy-eight SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the Beta variant.
KenyaCOVID-19observed March 2020 – September 2022published 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument of 8 observationsDOI 10.1101/2022.10.26.22281446
0.5 ratioChildren living more than 2.5 km from the nearest road had severe malaria admission rates that were about half of those for children living within 0.5 km of a road.
Kenyapaludismepublished 1998International journal of epidemiologyeurope_pmcdocument of 2 observations
25 %Among 241 adults newly diagnosed with Kaposi sarcoma in Kenya and Uganda from 2016 to 2019, 25% had two ACTG T1 qualifying symptoms.
Kenyasarcome de Kaposiobserved 2016 to 2019published 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations
The JiPime-JiPrEP trial found non-inferior HIV testing, PrEP refilling, and adherence for six-month PrEP dispensing supported with interim HIV self-testing compared to three-month PrEP dispensing and quarterly clinic visits.
KenyaVIH/sidapublished 2025BMC health services researchPubMeddocument of 11 observations
3.2 %The pooled yield of active tuberculosis across studies was 3.2%.
Kenyatuberculosepublished 2022Tuberculosis research and treatmenteurope_pmcdocument of 8 observationsDOI 10.1155/2022/9947068
0.29 aORBacterial vaginosis was associated with fewer episodes of vulvovaginal candidiasis (VVC) with an adjusted odds ratio of 0.29.
Kenyavaginose bactérienne · vulvovaginal candidiasis (VVC)published 2009The Journal of infectious diseaseseurope_pmcdocument of 5 observationsDOI 10.1086/599213
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.